We’re delighted to share highlights from our recent workshop “Framing JUST solutions for ACCESS to treatment against AMR”! Fantastic participants, candid challenge-sharing, and lively, solutions-focused discussions throughout the day.
Read more: https://t.co/WhhFKEI7E2
Big thanks to a great group of co-authors - Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa | Clinical Microbiology Reviews https://t.co/NXVs5855Zm
New RCT from @UQMedicine Cefiderocol versus standard therapy for healthcare-associated Gram-negative BSI @UQ_GAMECHANGER@UQ_News >500 patients in 6 countries with high rates of MDR; 25% carb-R; Non-inferior but not superior for 14d mortality @TheLancetInfDis@davidantibiotic
Congratulations @OffCMCVellore on retaining #NIRF ranking as 3rd best Medical College in India. @dpradhanbjp
Benchmarks help but staying true to the call to "Not to be ministered unto, but to minister" will define who we really are meant to be.
Three cheers to the Silver & Blue
📅 Save the Date: ACC2026
The Antimicrobial Chemotherapy Conference (ACC2026) is coming your way in February 2026!
This year, GARDP and @BSACandJAC are teaming up with @ADVANCE__ID and @MahidolU to develop this one-of-a-kind online conference.
🗓️ Programme details and registration coming in September
In the meantime, take a look back at past conferences:
🔗 https://t.co/PWZWxnxHqR
A new @guardian article highlights the alarming economic impact of AMR if we continue business as usual.
The report findings are —
💸 $2 trillion in global economic losses annually by 2050
📷 Millions of lives at risk from drug-resistant infections
Cuts to AMR programmes, especially in LMICs, could accelerate resistance globally, even in countries that have kept it under control.
But the research also offers a clear message that investing now in new antibiotics and equitable access will save lives and deliver long-term economic returns.
At GARDP, we're working to ensure that lifesaving treatments are developed and reach the people who need them most.
📖 Read the article in The Guardian:
https://t.co/GERwsR30em
🌍 Learn more about our work:
https://t.co/9FsGnhDsvh
@CGDev
#ThisIsBig #AMR #Superbugs #GARDP
We commence Day 1 of our 13th Annual Conclave 2025 today, a three-day event happening from 16–18 July.
The day opened with Lightning Talks, where our Fellows gave a rapid overview of their research.
Follow this thread for more updates and highlights from Day 1 of the Conclave.
🚩 A milestone in the fight against #AMR
Congratulations to @Roche on advancing zosurabalpin into Phase 3 trials—a potential first-in-class antibiotic against Carbapenem-resistant Acinetobacter baumannii and other Gram-negative bacteria in over 50 years.
This kind of bold innovation is urgently needed. We applaud Roche’s commitment to tackling one of the toughest global health threats of our time.
🔗 https://t.co/EKrpTeiUX3
#AntibioticResistance #Roche #Innovation #GARDP
https://t.co/peW2qqvFGS
Landmark study with international collaboration & CMC partnership conducted across diverse range of hospitals in countries in 3 continents - #India, #Brazil & #Malawi - showed improvement in diagnosis and management for #patients with acute brain #infections, after introduction of a simple, multifaceted intervention package.
Intervention now being implemented in various settings as part of @WHO #Meningitis Roadmap and #encephalitis control initiatives.
@b5ingh@RupaliPriscilla@RunningMadProf
ICMR AMR team will be sharing Indian experiences from Antimicrobial resistance surveillance network at IVI AMR TRAINING @IVIHeadquarters@seoul@ICMRDELHI
One of life’s greatest joys is to spread the gospel of the superiority of ORAL antibiotics
All are welcome in our church!
At our next ceremony we will be burning PICC lines and reciting the liturgy of oral bioavailability
Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial
https://t.co/y43lAVd6gy
Really proud of the amazing work Prof @PaulTurnerMicro and Dr Claudia have done to support children’s health in Cambodia! 🇬🇧 ♥️ 🇰🇭
@angkorhospital is an amazing facility that offers care free of charge, with special expertise in treating cancer & trauma injuries in children 😍